ロード中...
Excision Repair Cross-complementation Group 1 is a Prognostic Biomarker in Patients with Colorectal Cancer Receiving Chemotherapy
BACKGROUND: Conflicting results about the association between expression level of excision repair cross-complementation group 1 (ERCC1) and clinical outcome in patients with colorectal cancer (CRC) receiving chemotherapy have been reported. Thus, we searched the available articles and performed the...
保存先:
| 出版年: | Chin Med J (Engl) |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Medknow Publications & Media Pvt Ltd
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4804441/ https://ncbi.nlm.nih.gov/pubmed/26904994 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0366-6999.176993 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|